HK1256968A1 - Stable and palatable composition of vitamin c and zinc lozenge tablets - Google Patents

Stable and palatable composition of vitamin c and zinc lozenge tablets

Info

Publication number
HK1256968A1
HK1256968A1 HK18116108.5A HK18116108A HK1256968A1 HK 1256968 A1 HK1256968 A1 HK 1256968A1 HK 18116108 A HK18116108 A HK 18116108A HK 1256968 A1 HK1256968 A1 HK 1256968A1
Authority
HK
Hong Kong
Prior art keywords
vitamin
stable
palatable composition
lozenge tablets
zinc
Prior art date
Application number
HK18116108.5A
Other languages
Chinese (zh)
Inventor
溫德爾‧G‧門多撒
麗塔‧約瑟菲娜‧M‧桑托斯
肯尼‧U‧迪伊
Original Assignee
諾維克斯科技私人有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 諾維克斯科技私人有限公司 filed Critical 諾維克斯科技私人有限公司
Publication of HK1256968A1 publication Critical patent/HK1256968A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18116108.5A 2016-01-15 2018-12-14 Stable and palatable composition of vitamin c and zinc lozenge tablets HK1256968A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/PH2016/000001 WO2017123103A1 (en) 2016-01-15 2016-01-15 Stable and palatable composition of vitamin c and zinc lozenge tablets

Publications (1)

Publication Number Publication Date
HK1256968A1 true HK1256968A1 (en) 2019-10-04

Family

ID=59311387

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116108.5A HK1256968A1 (en) 2016-01-15 2018-12-14 Stable and palatable composition of vitamin c and zinc lozenge tablets

Country Status (9)

Country Link
KR (1) KR20180101530A (en)
CN (1) CN108495621A (en)
AU (1) AU2016386385B2 (en)
BR (1) BR112018013689A2 (en)
HK (1) HK1256968A1 (en)
NZ (1) NZ744260A (en)
PH (1) PH12018501438A1 (en)
SG (1) SG11201805821UA (en)
WO (1) WO2017123103A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018007634A2 (en) * 2015-10-16 2018-11-06 Dee Kennie stable coated oral tablet

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
FR2883182B1 (en) * 2005-03-16 2008-02-15 Novartis Ag VITAMIN COMPOSITION USEFUL IN THE TREATMENT OF OCULAR DISEASES
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US8491937B2 (en) 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
EP2385769A4 (en) * 2008-12-15 2014-08-20 Valeant Pharmaceuticals Luxembourg S R L Rapidly dissolving vitamin formulation and methods of using the same

Also Published As

Publication number Publication date
CN108495621A (en) 2018-09-04
BR112018013689A2 (en) 2019-04-30
NZ744260A (en) 2020-07-31
AU2016386385B2 (en) 2020-05-21
WO2017123103A1 (en) 2017-07-20
KR20180101530A (en) 2018-09-12
WO2017123103A8 (en) 2018-07-26
PH12018501438A1 (en) 2018-11-05
AU2016386385A1 (en) 2018-07-26
SG11201805821UA (en) 2018-08-30

Similar Documents

Publication Publication Date Title
IL252477A0 (en) 2-aminopyrimidine compound and pharmaceutical composition and use thereof
GB201620066D0 (en) Solid Pharmaceutical dosage formulations and processes
HK1224191A1 (en) Pyridylaminoacetic acid compound and polyoxyethylene castor oil- containing pharmaceutical composition
IL272168A (en) Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
SG11201605868XA (en) Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient
IL248090B (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
EP3500566A4 (en) Spirocyclic containing compounds and pharmaceutical uses thereof
HK1245086A1 (en) Pharmaceutical composition preparation and uses thereof
EP3275453A4 (en) Pharmaceutical composition containing silybin and ve
EP3111939A4 (en) Vitamin d and antibacterial uses of composition thereof
EP3313187A4 (en) Sustained release formulation and tablets prepared therefrom
HK1245085A1 (en) Pharmaceutical composition preparation and uses thereof
EP3166649A4 (en) Aqueous extract of truffle and cosmetic composition thereof
RS60393B1 (en) Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets
ZA201807125B (en) Pharmaceutical composition of dapagliflozin
HK1257130A1 (en) Stable composition of vitamin c and zinc tablet
IL254794B (en) Pharmaceutical formulations of pyridinium compound and permeability enhancer or base
SG10202008700VA (en) α-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF
IL267279A (en) Pharmaceutical formulations of suvorexant
EP3532052A4 (en) Design and composition of cell-stabilized pharmaceutical formulations
EP3110403A4 (en) Taste masking drug formulations
PT3503885T (en) Pharmaceutical composition and methods of uses
HK1256968A1 (en) Stable and palatable composition of vitamin c and zinc lozenge tablets
EP3558300A4 (en) Solid pharmaceutical formulations of asimadoline
EP3454851A4 (en) Compositions comprising substituted benzofuroquinolizine and psychoactive drug